Modern Pharmaceuticals submits vaccine approval request to regulators

This urgent request by the pharmaceutical company comes after new results that, according to Moderna, showed an efficiency of 94%, data that show consistency with the tests related to phase 3.

The North American pharmaceutical company today announced the request for emergency use of its vaccine for covid-19 to European and North American medicine regulators.

The company also revealed that the final results of clinical trials of the vaccine against the new coronavirus indicate an effectiveness of 94,1 percent.

The efficacy and safety shown by the vaccine - which caused temporary side effects similar to flu symptoms - meet the requirements of the US agency, the FDA, for an emergency use authorization even before the entire testing phase is complete.

The European Medicines Agency has also expressed its openness to authorize the use of the drug.

Moderna revealed that there are no safety problems with its vaccine, with side effects and limited to momentary pain at the injection site, headaches and fatigue.

The announcement of the approval request came shortly after another similar one made by pharmaceutical companies Pfizer and BioNTech, whose vaccines, such as Moderna's, use messenger RNA technology, a new technique that allows the use of a cellular protein generation mechanism to generate the desired immunity response against a virus like SARS-CoV-2.

Moderna's vaccine, however, does not need minus 70 degrees below zero, as is the case with Pfizer, so its transport and storage would be cheaper and more accessible to rural areas or developing economies.

After announcing that they would proceed with the order, the pharmaceutical company's shares appreciated 11% in the negotiations before the market opened. Thus, Moderna's shares are now valued at $ 141,40 (€ 118,06).

Read more

Marques Mendes says Portugal will receive 22 million doses of vaccines against Covid-19

Luís Marques Mendes said that, as of January, the country should start receiving the first doses of the vaccine and guarantees that “there will be vaccines for all Portuguese” and that this will be “universal and free for all Portuguese”.

Moderna will supply two million additional vaccines against Covid-19 to the United Kingdom

The American biotechnology company Modern announced today that it has reached an agreement to provide the United Kingdom with two million additional doses of its coronavirus vaccine, bringing the total to seven million.

Covid-19: Dispensing vaccines without difficulties but pharmacies may have problems

The pharmaceutical companies responsible for two of the most promising vaccines against covid-19 do not anticipate difficulties in distribution operations, but storage at vaccination sites will be more complex and pharmacies are only prepared to receive one.

Portugal registers new record of fatalities by Covid-19

Health authorities accounted for an additional 5.783 people recovered in the past 24 hours, bringing the total number of people free from the virus to 434.237.

Prosecutors call for suspension of non-urgent trials and investigations 

The union warns that, in view of the epidemiological situation, it is necessary to reduce activity to a minimum, at least, until the SNS response stabilizes and informs that it is notified of an increasing number of magistrates and judicial officials infected with the virus.

Masses suspended from Saturday, announces Episcopal Conference

Catecheses and “other pastoral activities that involve contact” are also canceled “until further notice”. In the case of the archipelagos of Madeira and the Azores, “own guidelines” will be given by the local dioceses.